Skip to main content
Premium Trial:

Request an Annual Quote

Bertrand Damour, Stephen Macevicz, Diana Wetmore, Ben Bowen


GeneProt, based in Evanston, Ill., has made three appointments to its senior management team.

Bertrand Damour, most recently senior vice president and co-head of the investment banking risk management group at JP Morgan in London, joined the company as CFO; Stephen Macevicz, formerly vice president of legal affairs at Lynx Therapeutics, was hired as vice president of intellectual property; and Diana Wetmore, most recently senior director of R&D project management at Anadys Pharmaceuticals, will serve as CTO for GeneProt’s Geneva branch.


Pittsburgh-based bioinformatics incubator LaunchCyte has appointed seven new science and business executives to its advisory board: Ben Bowen, vice president of application development for Lynx Therapeutics; S. Thomas Emerson, director of the Donald H. Jones Center for Entrepreneurship at Carnegie Mellon University; George Fechter, associate vice chancellor for external relations of the health sciences at the University of Pittsburgh; Jack Kincaid, CEO of IT accelerator Business Strategies Group; Henri Lipmanowicz, former chief of international operations for Merck; Alan Russell, executive director of the Pittsburgh Tissue Engineering Initiative; Robert Shapiro, former CEO of Monsanto and recently retired chairman of Pharmacia Corp.; and Mohamed Virji, director for the division of clinical chemistry in the department of pathology at the University of Pittsburgh School of Medicine and the Medical Center.


Paul Jackson and Thomas Terwilliger of the Bioscience Division of Los Alamos National Laboratory were among six new Laboratory Fellows recently selected by lab director John Browne. The distinction is the lab’s highest scientific honor.

Jackson was recognized for his research in molecular and cellular biology, while Terwilliger was recognized for his role in the development of the computer program Solve, which creates automated solutions of protein crystal structures from X-ray diffraction data sets.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.